Brimonidine Labatec 2 mg/ml, collyre en solution
7680685270016
CH-68527
S01EA05
11.09.0.
1 / 3
google
Details
- Product number
- 6852701
- CPT
- -
- Packaging group
- 5
- Unit
- ml
- Composition
- brimonidini tartras 2 mg corresp. brimonidinum 1.3 mg, poly(alcohol vinylicus), natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, benzalkonii chloridum 50 µg, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Brimonidine Labatec 2 mg/ml, collyre en solution
Augentropfen
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
1.3 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
50.0 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 68527
- Drug name
- Brimonidine Labatec 2 mg/ml, collyre en solution
- Galenic form
- AUL
- ATC Code
- S01EA05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/01/2023
- Authorization expiration date
- 17/01/2028
- IT number
- 11.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BRIMONIDINE Labatec gtt opht 2 mg/ml fl 5 ml
- Description (DE)
- BRIMONIDINE Labatec Gtt Opht 2 mg/ml Fl 5 ml
- Narcotic (BTM)
- No